As part of the first-in-human trial, participants received more than 15 times the standard dose of the chemotherapy drug doxorubicin every 21 days for up to one year. “Usually, a patient can only ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology ...

Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain ...

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three ...

Preclinical testing by Hungarian researchers has shown that a newly developed compound can eliminate aggressive tumors in ...

Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...

Mountain Valley MD ( ($TSE:MVMD) ) has issued an announcement. Mountain Valley MD issued a year-end update highlighting commercialization progress ...

InnoCan Pharma ( ($TSE:INNO) ) has shared an update. Innocan Pharma Corporation plans to list its common shares on the NYSE American around ...

Consumer Analysis Examines Multi-Form Magnesium Formulation, Quality Testing Protocols, and Research Context as New Year ...

The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...

Researchers from the Indian Institute of Technology Madras (IIT Madras, Monash University and Deakin University, Australia, have developed a nanoinjection drug delivery platform for breast cancer drug ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...